Trial intelligence / Profile preview

Sequenced Behavioral and Medication Intervention for Cocaine Dependence

NCT01986075Phase 2Completed

Sponsor
New York State Psychiatric Institute
Start
Jan 2014
Primary completion
Jan 2021
Modality
Small Molecules, Drug Delivery Systems
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in cocaine dependence comparing Adderall XR + CBT with Placebo + CBT (2 arms). Primary endpoint: Proportion Achieving Three Consecutive Weeks of Cocaine Abstinence at 14 weeks. Started Jan 2014; status: completed.

02

Drugs

adderall xr
03

Conditions

cocaine dependence

Beyond the preview

Go deeper on NCT01986075.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01986075.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call